¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : ÖìÓñÏÍ·Ö×ӿμþ£¨Ðø£©
¼¶±ð: ³õ¼¶²©ÓÑ
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2009-09-08   

ÖìÓñÏÍ·Ö×ӿμþ£¨Ðø£©

µÚÎå½² ·Ö×ÓÉúÎïѧÑо¿·¨ MbxJ3"@  
Ò»¡¢ ÖØ×éDNA¼¼Êõ·¢Õ¹Ê·ÉϵÄÖØ´óʼþ ^EJ]LNk }  
1.40Äê´úÈ·¶¨ÁËÒÅ´«ÐÅÏ¢µÄЯ´øÕߣ¬¼´»ùÒòµÄ·Ö×ÓÔØÌåÊÇDNA¶ø²»Êǵ°°×ÖÊ£¬½â¾öÁËÒÅ´«µÄÎïÖÊ»ù´¡ÎÊÌ⣻ yMEI^,0"  
2.50Äê´úÌáʾÁËDNA·Ö×ÓµÄË«ÂÝÐý½á¹¹Ä£ÐÍºÍ°ë ±£Áô¸´ÖÆ»úÖÆ,½â¾öÁË»ùÒòµÄ×ÔÎÒ¸´ÖƺÍÊÀ´ú½»ÌæÎÊÌ⣻ y[ZVi5) ,  
3.50Äê´úÄ©ÖÁ60Äê´ú£¬Ïà¼ÌÌá³öÁË"ÖÐÐÄ·¨Ôò"ºÍ²Ù×Ý×Óѧ˵,³É¹¦µØÆÆÒëÁËÒÅ´«ÃÜÂ룬³ä·ÖÈÏʶÁËÒÅ´«ÐÅÏ¢µÄÁ÷¶¯ºÍ±í´ï¡£ }Te+Rv7{E  
Äê·Ý ÊÂ ¼þ 4-BrE&2f  
1869 F MiescherÊ״δÓÀ³ÒðºÓöÙÓ㾫×ÓÖзÖÀëDNA¡£ O03F@v  
1944 O.T. Avery֤ʵDNAÊÇÒÅ´«ÎïÖÊ¡£ T|p%4hH  
1952 A.D. HersheyºÍM.ChaseÔÙ´Î֤ʵºÍÊɾúÌåµÄÒÅ´«ÎïÖÊÊÇDNA¡£ g_@b- :$Yq  
1953 J.D.WatsonºÍF.H.C.CrickÌá³öDNA·Ö×ӽṹµÄË«ÂÝÐýÄ£ÐÍ¡£M.WilkinsÓÃX-ÉäÏßÑÜÉ䷨֤ʵÁËÕâÒ»½á¹¹¡£ Pv|sPIIB7  
1957 A.Kornberg´Ó´ó³¦¸Ë¾úÖз¢ÏÖÁËDNA¾ÛºÏøI¡£ &14xYpD<  
1958 M. MeselsonºÍF. W. StahlÌá³öÁËDNAµÄ°ë±£Áô¸´ÖÆÄ£ÐÍ¡£ O>>/2V9  
1959-1960 S. Ochoa·¢ÏÖRNA¾ÛºÏøºÍÐÅʹRNA£¬²¢Ö¤Ã÷mRNA¾ö¶¨Á˵°°×ÖÊ·Ö×ÓÖеݱ»ùËáÐòÁС£ MP_/eC ;  
1961 NirenbergÆÆÒëÁ˵ÚÒ»ÏàÒÅ´«ÃÜÂ룻F. JacobºÍJ. MonodÌá³öÁ˵÷½Ú»ùÒò±í´ïµÄ²Ù×Ý×ÓÄ£ÐÍ¡£  PZY6 I  
1964 C. YanofskyºÍS. BrennerµÈÈËÖ¤Ã÷£¬¶àëÄÁ´Éϵݱ»ùËáÐòÁÐÓë¸Ã»ùÒòÖеĺËÜÕËáÐòÁдæÔÚ׏²ÏßÐÔ¹ØÏµ¡£ Bjh8uW G  
1965 S. W. HolleyÍê³ÉÁ˽Íĸ±û°±ËátRNAµÄÈ«ÐòÁвⶨ£»¿ÆÑ§¼ÒÖ¤Ã÷ϸ¾úµÄ¿¹Ò©ÐÔͨ³£ÓÉ"ÖÊÁ£"DNAËù¾ö¶¨¡£ /8 y v8  
1966 M.W.Nirenberg£¬S.Ochoa¡¢H.G.Khorana¡¢F.H.C.CrickµÈÈËÆÆÒëÁËÈ«²¿ÒÅ´«ÃÜÂë¡£ pgW^hj\  
1970 H.O.Smith£¬K.W.WilcoxºÍT.J.Kelley·ÖÀëÁ˵ÚÒ»ÖÖÏÞÖÆÐÔºËËáÄÚÇÐø¡£H.M.TeminºÍD.Baltimore´ÓRNAÖ×Áö²¡¶¾Öз¢ÏÖ·´×ªÂ¼Ã¸¡£ N/[!$B0H@  
1972-1973 H.Boyer£¬P.BergµÈÈË·¢Õ¹ÁËDNAÖØ×é¼¼Êõ£¬ÓÚ72Äê»ñµÃµÚÒ»¸öÖØ×éDNA·Ö×Ó£¬73ÄêÍê³ÉµÚÒ»Àýϸ¾ú»ùÒò<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡¡£ wb%4f6i  
1975-1977 F.SangerÓëA.Maxam¡¢W.GilbertµÈÈË·¢Ã÷ÁËDNAÐòÁвⶨ¼¼Êõ¡£1977ÄêÍê³ÉÁËÈ«³¤5387bpµÄÊɾúÌå¦Õ174»ùÒò×é²â¶¨¡£ \p%D;g+c  
1978 Ê×´ÎÔڴ󳦸˾úÖÐÉú²úÓÉÈ˹¤ºÏ³É»ùÒò±í´ïµÄÈËÄÔ¼¤ËغÍÈËÒȵºËØ¡£ S_ra8HY8  
1980 ÃÀ¹úÁª°î×î¸ß·¨Ôº²Ã¶¨Î¢ÉúÎï»ùÒò¹¤³Ì¿ÉÒÔרÀû»¯¡£ W.59Al'  
1981 R. D. PalmiterºÍR. L. Brinster»ñµÃ<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: Article Search.asp?Field="Title&ClassID=&keyword=%D7%AA%BB%F9%D2%F2&Submit=+%CB%D1%CB%F7+¡¯" bbioo.com>ת»ùÒòСÊó£»A. C. SpradlingºÍG. M. RubinµÃµ½<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: Article Search.asp?Field="Title&ClassID=&keyword=%D7%AA%BB%F9%D2%F2&Submit=+%CB%D1%CB%F7+¡¯" bbioo.com>ת»ùÒò¹ûÓ¬¡£ !^EA}N.u  
1982 ÃÀ¡¢Ó¢Åú׼ʹÓõÚÒ»Àý»ùÒò¹¤³ÌÒ©Îï--ÒȵºËØ£»SangerµÈÈËÍê³ÉÁËÈëÊɾúÌå48,502bpÈ«ÐòÁвⶨ¡£ YV'B*arIA  
1983 »ñµÃµÚÒ»Àý<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: Article Search.asp?Field="Title&ClassID=&keyword=%D7%AA%BB%F9%D2%F2&Submit=+%CB%D1%CB%F7+¡¯" bbioo.com>ת»ùÒòÖ²Îï¡£ P~V ^Efz{  
1984 ˹̹¸£´óѧ»ñµÃ¹ØÓÚÖØ×éDNAµÄרÀû¡£ t. HwX9  
1986 GMOÊ×´ÎÔÚ»·¾³ÖÐÊÍ·Å¡£ 2Ima15^+F  
1988 J. D. Watson³öÈÎ"ÈËÀà»ùÒò×鼯»®"Ê×ϯ¿ÆÑ§¼Ò¡£ dA<SVk*0Q  
1989 DuPont¹«Ë¾»ñµÃתÖ×Áö»ùÒòСÑõ--"Oncomouse"¡£ [x- 9m\ h  
1992 Å·¹²Ìå35¸öʵÑéÊÒÁªºÏÍê³É½ÍĸµÚÈýȾɫÌåÈ«ÐòÁвⶨ(315kb) xiL+s-   
1994 µÚÒ»Åú»ùÒò¹¤³ÌÎ÷ºìÊÁÔÚÃÀ¹úÉÏÊС£ /8u}VYE  
1996 Íê³ÉÁ˽Íĸ»ùÒò×é(1.25¡Á107bp)È«ÐòÁвⶨ¡£ CtUAbR  
1997 Ó¢¹ú°®¶¡±¤ÂÞ˹ÁÖÑо¿Ëù»ñµÃ<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡Ñò¡£ 9{rE7OX*A  
»ùÒò¹¤³ÌÖг£¼ûµÄÃû´Ê: 2IP<6l8N  
ÒÅ´«¹¤³Ì--genetic engineering£¬»ùÒò²Ù×÷--gone manipulation£¬»ùÒò<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡--gone cloning£¬ /7ShE-.5#  
ÖØ×éDNA¼¼Êõ--recombinant DNA technology£¬·Ö×Ó<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡--molecular cloning¡£ /XNC^!z6Js  
»ùÒò¹¤³ÌµÄÖ÷ÒªÄÚÈÝ»ò²½Öè: |+Z-'k~Q  
1. ´ÓÉúÎïÓлúÌå»ùÒò×éÖУ¬·ÖÀë³ö´øÓÐÄ¿µÄ»ùÒòµÄDNAƬ¶Î¡£ Q'Uv5p"X  
2. ½«´øÓÐÄ¿µÄ»ùÒòµÄÍâÔ´DNAƬ¶ÎÁ¬½Óµ½Äܹ»×ÔÎÒ¸´ÖƵIJ¢¾ßÓÐÑ¡Ôñ¼ÇºÅµÄÔØÌå·Ö×ÓÉÏ£¬ÐγÉÖØ×éDNA·Ö×Ó¡£ L>lxkq8!Q  
3. ½«ÖØ×éDNA·Ö×Ó×ªÒÆµ½Êʵ±µÄÊÜÌåϸ°û£¨Òà³Æ¼ÄÖ÷ϸ°û£©²¢ÓëÖ®Ò»ÆðÔöÖ³¡£ y5?kv-"c  
4. ´Ó´óÁ¿µÄϸ°û·±Ö³ÈºÌåÖУ¬É¸Ñ¡³ö»ñµÃÁËÖØ×éDNA·Ö×ÓµÄÊÜÌåϸ°û£¬²¢É¸Ñ¡³öÒѾ­µÃµ½À©ÔöµÄÄ¿µÄ»ùÒò¡£ Q=Q&\.<  
5. ½«Ä¿µÄ»ùÒò<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡µ½±í´ïÔØÌåÉÏ£¬µ¼Èë¼ÄÖ÷ϸ°û£¬Ê¹Ö®ÔÚеÄÒÅ´«±³¾°ÏÂʵÏÖ¹¦Äܱí´ï£¬²úÉú³öÈËÀàËùÐèÒªµÄÎïÖÊ¡£ hpq\  
]ki) (Bb  
¶þ¡¢ »ùÒò²Ù×÷µÄÖ÷Òª¼¼ÊõÔ­Àí {bC(>k|CQ  
1£® ºËËáµÄÄý½ºµçÓ¾(Agarose & Polyacrylamide) ;y)3/46S  
½«Ä³ÖÖ·Ö×ӷŵ½Ìض¨µÄµç³¡ÖУ¬Ëü¾Í»áÒÔÒ»¶¨µÄËÙ¶ÈÏòÊʵ±µÄµç¼«Òƶ¯¡£Ä³ÎïÖÊÔڵ糡×÷ÓÃϵÄÇ¨ÒÆËٶȽÐ×÷µçÓ¾µÄËÙÂÊ£¬ËüÓëµç³¡Ç¿¶È³ÉÕý±È£¬Óë¸Ã·Ö×ÓËùЯ´øµÄ¾»µçºÉÊý³ÉÕý±È£¬¶øÓë·Ö×ÓµÄÄ¥²ÁϵÊý³É·´±È£¨·Ö×Ó´óС¡¢¼«ÐÔ¡¢½éÖʵÄÕ³¶ÈϵÊýµÈ£©¡£  B`vC>  
ÔÚÉúÀíÌõ¼þÏ£¬ºËËá·Ö×ÓÖеÄÁ×Ëá»ùÍÅÊÇÀë×Ó»¯µÄ£¬ËùÒÔ£¬DNAºÍRNAʵ¼ÊÉϳʶà¾ÛÒõÀë×Ó״̬£¨Polyanions£©¡£½«DNA¡¢RNA·Åµ½µç³¡ÖУ¬Ëü¾Í»áÓɸº¼«¡úÕý¼«Òƶ¯¡£ \5a;_N[Ed  
ÔÚÄý½ºµçÓ¾ÖУ¬Ò»°ã¼ÓÈëä廯ÒÒ¶§£¨EB£©--ethidium bromideȾɫ£¬´Ëʱ£¬ºËËá·Ö×ÓÔÚ×ÏÍâ¹âÏ·¢³öÓ«¹â£¬ÈâÑÛÄÜ¿´µ½Ô¼50ng DNAËùÐγɵÄÌõ´ø¡£ 0d89>UB-8q  
DNAµÄÂö³åµçÓ¾¼¼Êõ :PFGE-Pulse-field gel electrophoresis zFY$^Oz"_  
2£® ºËËáµÄ·Ö×ÓÔÓ½»¼¼Êõ .R#<Q  
ÔÚ´ó¶àÊýºËËáÔÓ½»·´Ó¦ÖУ¬¾­¹ýÄý½ºµçÓ¾ ·ÖÀëµÄDNA»òRNA·Ö×Ó£¬¶¼ÊÇÔÚÔÓ½»Ö®Ç°£¬Í¨¹ýëϸ¹Ü×÷Óûòµçµ¼×÷Óð´ÆäÔÚÄý½ºÖеÄλÖÃÔ­·â²»¶¯µØ"ÎüÓ¡" ×ªÒÆµ½ÂËĤÉϵġ£³£ÓõÄÂËĤÓÐÄáÁúÂËĤ¡¢ÏõËáÏËÎ¬ËØÂËĤ£¬µþµª±½Ñõ¼×»ùÏËÎ¬ËØÂËÖ½£¨DBM£©ºÍ¶þÒÒ°±»ùÒÒ»ùÏËÎ¬ËØÂËĤ£¨DEAE£©µÈ¡£ dIA1\;@  
ºËËá·Ö×ÓÔÓ½»ÊµÑé°üÀ¨ÈçÏÂÁ½¸ö²½Ö裺 VkId6k:>6C  
½«ºËËáÑùÆ·×ªÒÆµ½¹ÌÌåÖ§³ÖÎïÂËĤÉÏ£¬Õâ¸ö¹ý³ÌÌØ³ÆÎªºËËáÓ¡¼£(nucleic acid blotting)×ªÒÆ£¬Ö÷ÒªÓеçÓ¾Äý½ººËËáÓ¡¼£·¨¡¢°ßµãºÍÏÁÏßÓ¡¼£·¨(dot and slot blotting)¡¢¾úÂäºÍÊɾú°ßÓ¡¼£·¨(colony and plaque blotting)£» -k%|sqDZj  
½«¾ßÓкËËáÓ¡¼£µÄÂËĤͬ´øÓзÅÉäÐÔ±ê¼Ç»òÆäËü±ê¼ÇµÄDNA»òRNA̽Õë½øÐÐÔÓ½»¡£ËùÒÔÓÐʱҲ³ÆÕâÀàºËËáÔÓ½»ÎªÓ¡¼£ÔÓ½»¡£ 1l^ `  
3£® ϸ¾úµÄת»¯ +O8}twt@  
Ëùνϸ¾úת»¯£¬ÊÇÖ¸Ò»ÖÖϸ¾ú¾úÖêÓÉÓÚ²¶»ñÁËÀ´×ÔÁíÒ»ÖÖϸ¾ú¾úÖêµÄDNA£¬¶øµ¼ÖÂÐÔ×´ÌØÕ÷·¢ÉúÒÅ´«¸Ä±äµÄÉúÃü¹ý³Ì¡£ÕâÖÖÌṩת»¯DNAµÄ¾úÖê½Ð×ö¹©Ìå¾úÖ꣬¶ø½ÓÊÜת»¯DNAµÄ¼ÄÖ÷¾úÖêÔò³Æ×öÊÜÌå¾úÖê¡£´ó³¦¸Ë¾úÊÇ×î¹ã·ºÊ¹ÓõÄʵÑé¾úÖê¡£ÔÚ¼ÓÈëת»¯DNA֮ǰ£¬±ØÐëÔ¤ÏÈÓÃCaCl2´¦Àí´ó³¦¸Ë¾úϸ°û£¬Ê¹Ö®³Ê¸ÐÊÜ̬£¨Competent Cells£©¡£Mg2+¶Ôά³ÖÍâÔ´DNAµÄÎȶ¨ÐÔÆðÖØÒª×÷Óã¬ÖÊÁ£DNAÖеĿ¹ÉúËØÊÇɸѡ±ê¼Ç¡£ gEmsPk,  
¶Ô¾ø´ó¶àÊýhsdR-£¬hsdM-Í»±äÌå¾úÖ꣨k12£©£¬Ã¿ug DNA¿ÉµÃ107-108¸öת»¯×Ó¡£ [t*-s1cq  
4£® DNAÐòÁзÖÎö ' R= OeH  
a. SangerµÄË«ÍÑÑõÁ´ÖÕÖ¹·¨ dd@ D s  
CambridgeµÄF. SangerÔÚ1977Äê·¢Ã÷ÓÃË«ÍÑÑõÁ´ÖÕÖ¹·¨²â¶¨µ¥Á´DNAµÄÐòÁУ¬Æä»ù±¾Ô­ÀíÈçÏ£º %4/X;w\3  
¢ÙDNA¾ÛºÏøÄܹ»Óõ¥Á´DNA×÷Ϊģ°å£¬ºÏ³É׼ȷµÄDNA»¥²¹Á´£»¢Ú¸ÃøÄܹ»ÓÃ2¡¯£¬3¡¯--Ë«ÍÑÑõºËÜÕÈýÁ×Ëá×÷µ×Îï²¢½«Æä¾ÛºÏµ½ÐÂÉú¹ÑºËÜÕËáÁ´µÄ3¡¯-Ä©¶Ë£¬´Ó¶øÖÕÖ¹ÆäÑÓÉì·´Ó¦¡£ÔÚDNA²âÐò·´Ó¦ÖУ¬¼ÓÈëÄ£°åDNA£¬ÒýÎï£¨ÌØÒìÐÔÒýÎÈçT7£¬T3£¬M13µÈ£©£¬DNA¾ÛºÏø£¬dA£¬dT£¬dG£¬dCºÍÒ»ÖÖddNTP¡£³£ÓÃKlenow´óƬ¶Î£¬ÎÞ5¡¯¡ú3¡¯ÍâÇÐø»îÐÔ¡£ \}gITc).j  
b£® Maxam-Gilbert»¯Ñ§ÐÞÊη¨(¹þ·ð´óѧ) vJQ_mz  
¸Ã·½·¨µÄ»ù±¾Ô­ÀíÊÇÓû¯Ñ§ÊÔ¼Á´¦Àí¾ßÓÐÄ©¶Ë·ÅÉäÐÔ±ê¼ÇµÄDNAƬ¶Î£¬Ôì³É¼î»ùµÄÌØÒìÐÔÇи²úÉúÒ»×é¾ßÓв»Í¬³¤¶ÈµÄDNAÁ´½µ½â²úÎ¾­Äý½ºµçÓ¾·ÖÀëºÍ·ÅÉä×ÔÏÔÓ°Ö®ºó£¬¿ÉÖ±½Ó¶Á³ö´ý²âDNAƬ¶ÎµÄºËÜÕËáÐòÁС£ 7!e kINQ  
¸Ã·´Ó¦µÄ¹Ø¼üÔÚÓÚʹDNAµÄ4ÖÖºËÜÕËáÖУ¬Ö»ÓÐ1-2ÖÖ·¢ÉúÌØÒìÐԵĻ¯Ñ§ÇиӦ£º uK[gI6M  
¼î»ùµÄÌØÒìÐÔÐÞÊΣ» n]K{-C;  
±»ÐÞÊεļî»ù´ÓºËÌÇ»·ÉÏ×ªÒÆ£» .|y{1?f_  
ʧȥ¼î»ùµÄÌÇ»·²¿Î»·¢ÉúDNAÁ´¶ÏÁÑ¡£ Fl\kt.G  
רÃÅÓÃÀ´¶ÔºËÜÕËá×÷»¯Ñ§ÐÞÊΣ¬²¢´ò¶ÏÁ×Ëá¶þõ¥¼üµÄ»¯Ñ§ÊÔ¼ÁÓÐÁòËá¶þ¼×õ¥(dimethylsulphate)ºÍëÂ(hydrazine)¡£ T1RICIf 1F  
ÁòËá¶þ¼×õ¥ÊǼîÐÔ»¯Ñ§ÊÔ¼Á£¬ÄÜʹDNAÁ´ÖÐÄñàÑßʵÄN7ºÍÏÙàÑßʵÄN6λ·¢Éú¼×»ù»¯£¬ÔÚÖÐÐÔPH»·¾³ÖоÍÄÜʹÌÇÜÕ¼ü·¢ÉúË®½â£¬²¢ÒýÆðDNAÁ´µÄ¶ÏÁÑ¡£ÔÚ¼îÐÔÌõ¼þÏ£¬ëÂÄÜÌØÒìÐÔÇиîCºÍT¡£Èç¹û¼ÓÈë1 mol/LµÄNacl£¬ÄÇô£¬Ö»ÓÐC±»ÌØÒìÐÔÇи K48 QkZ_gY  
c£® DNAÐòÁзÖÎö×Ô¶¯»¯ '~xjaa;.  
ÓÃËļ׻ùÈôµ¤Ã÷(Tetramethylrhodamine)×÷Ϊӫ¹â¼Á±ê¼ÇDNAÒýÎ´øÓÐÕâÖÖÒýÎïµÄDNAƬ¶ÎÄÜÔÚ¼¤¹âÓÕµ¼Ï·¢³öÓ«¹â¡£°´ÕÕ±ê×¼µÄË«ÍÑÑõÖÕÖ¹·¨»ò»¯Ñ§ÖÕÖ¹·¨½øÐвâÐò·´Ó¦£¬ÅÜDNAÄý½ººóÓüÆËã»ú¼ì²â¡£ :|= Xh"l"  
d.DNAÔÓ½»²âÐò·¨(SBH-Sequencing by hybridization) )!sjXiC!h  
Èç¹ûÒ»¶Î½Ï¶ÌµÄDNA̽ÕëÄÜÓë½Ï³¤µÄDNAƬ¶ÎÔÓ½»£¬²¢ÐγÉÍêÈ«µÄË«Á´½á¹¹£¬ÎÒÃǾÍÍÆ²âÔÚ°ÐDNAÉÏ´æÔÚ×ÅÏàÓ¦µÄ»¥²¹ÐòÁУ¬Õâ¾ÍÊÇDNAÔÓ½»²âÐò·¨µÄ»ù±¾Ô­Àí¡£Èç¹û½«Ò»ÖÖ12-merµÄ°ÐDNAÓëÍêÈ«Ëæ»úºÏ³ÉµÄ8-mer¹ÑºËÜÕËá¿ØÕë»ìºÏÔÓ½»£¬ÔÚ×ÜÊýΪ48=65536ÖÖ8-merµÄ¿ØÕëȺÌåÖУ¬½öÓÐ5ÖÖ̽Õë»áÓë°ÐDNAÔÓ½»£¬ÐγÉÍêÈ«»¥²¹µÄË«Á´·Ö×Ó¡£ ?cD_\~  
µ±°ÐDNAÓë±ê¼Ç̽ÕëÐγÉG-T»òG-AÄ©¶Ë¼î»ù´íÅäµÄË«Á´Ìåʱ£¬¼ì²âÓÐÒ»¶¨ÄѶȡ£¹ÑºËÜÕËá̽ÕëÔ½¶Ì£¬¼î»ù´íÅäÔì³ÉµÄÈ¥Îȶ¨Ð§Ó¦Ô½Ã÷ÏÔ£¬½ÏÒ×ÓëÍêÈ«µÄË«Á´Ìå·Ö×ÓÏàÇø·Ö¡£µ«ÊÇ£¬Ì½Õë¶Ì£¬ÔÓ½»²úÎïµÄ×ÜÌåÎȶ¨ÐÔϽµ£¬ÐÅ/Ôë±ÈϽµ£¬Ó°Ïì½á¹ûµÄ¿É¿¿ÐÔ¡£ËùÒÔ£¬6-mer¹ÑºËÜÕËá¾ØÕóоƬֻÄÜÓÃÓڲⶨ500bpµÄ°ÐDNA£»7-mer=2000bp£¬8-mer=8000bp¡£ ? Lr: >  
SBHµÄÓ¦Ó㺠jG,^~ 5x  
¢Ù ¿ÉÓÐЧ¼ì²â°ÐDNAÖеĵ¥¼î»ùÍ»±ä£» :]`JcJ  
¢Ú ¿ÉÓÃÓÚ²»Í¬DNAƬ¶ÎÖ®¼äµÄÐòÁбȽϣ» "':SWKuMx  
¢Û ¿ÉÓÃÓÚ¼ì²â²»Í¬Éú³¤·¢Óý״̬ÏÂϸ°ûÖÐÌØ¶¨»ùÒòµÄ±í´ï×´¿ö£» / KKA/  
¢Ü ¿ÉÓÃÓÚ¼ìÑ鴫ͳ²âÐò¼¼ÊõµÄ׼ȷÐÔ¡£ n:JG+1I  
B_0]$D0 ^  
5£® »ùÒòµÄ¶¨µãÓձ䣨site-directed mutagenesis£© }ct*<zj[~u  
ʹÒÑ<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡»ùÒò»òDNAƬ¶ÎÖеÄÈκÎÒ»¸öÌØ¶¨¼î»ù·¢ÉúÈ¡´ú¡¢²åÈë»òȱʧ±ä»¯µÄ¹ý³Ì½Ð×÷»ùÒòµÄ¶¨µãÓձ䣬ÊÇ»ùÒò¹¤³ÌºÍµ°°×Öʹ¤³ÌµÄÖØÒªÊֶΡ£ ,.,Y{CP  
a. ºÐʽÓÕ±ä(cassette mutagenesis)£¬°üÀ¨ºÐʽȡ´úÓÕ±äºÍ»ìºÏ¹ÑºËÜÕËáÓÕ±äÁ½ÖÖ·½Ê½¡£ \6,Z<.I  
b£®¹ÑºËÜÕËáÒýÎïÓÕ±ä w6'8L s  
Ó¦Óû¯Ñ§ºÏ³ÉµÄº¬ÓÐÍ»±ä¼î»ùµÄ¹ÑºËÜÕËá¶ÌƬ¶Î×öÒýÎ½øÐÐDNA¸´ÖÆ£¬Ê¹¹ÑºËÜÕËáÒýÎï³ÉΪкϳɵÄDNA×ÓÁ´µÄÒ»¸ö²¿·Ö¡£ `R o>?H  
C£®PCRGÓëPCRÓÕ±ä `,6^eLU  
P/8z  
6£® ÀûÓÃDNAÓëµ°°×ÖʵÄÏ໥×÷ÓýøÐкËËáÑо¿. O9)k)A]`O  
a.Äý½ºÖÍ»ºÊµÑé(Gel retardation assay)£¬ÓÖ³ÆDNAÇ¨ÒÆÂʱ仯ÊÔÑé(DNA mobility shift assay--EMSA)¡£ Nv\<>gA:  
b£® DNase I Ó¡¼£ÊÔÑ飨DNase I foot printing£© ^4>Icz^ F  
Ö÷Òª²½Ö裺 t($z+ C<  
¢Ù ÓÃ32P±ê¼ÇDNAË«Á´Ä©¶Ë£¬²¢ÓÃREÇÐÈ¥Ò»¶Ë£» Z/I`XPmk  
¢Ú ¼ÓÈëϸ°ûÌØ¶¨ÖÜÆÚµ°°×ÖÊÌáÈ¡ÎÎÂÓý£» F2["AkNM  
¢Û ¼ÓÈëÊÊÁ¿DNaseI»òÁòËá¶þ¼×õ¥-ÁùÇâßÁण¬Ê¹DNAÁ´·¢Éú¶ÏÁÑ¡£ iTeFy -Ct  
ÕâÒ»·´Ó¦ÖУ¬DNaseI»òÁòËá¶þ¼×õ¥µÄÓÃÁ¿·Ç³£¹Ø¼ü£¬Òª±£Ö¤Ò»ÌõÁ´Ö»·¢ÉúÒ»´Î¶ÏÁÑ£¡ ZQrgYeQl"  
¢Ü³ÁµíDNA£¨°üÀ¨ÓëDNAÏà½áºÏµÄµ°°×ÖÊ£©£» ?[ v C?P  
¢Ý½øÐÐDNAÄý½º·ÖÎö¡£ &bS!>_9  
Èç¹ûij¸öµ°°×ÖÊÒѾ­ÓëDNAµÄÌØ¶¨Çø¶ÎÏà½áºÏ£¬ÄÇô£¬Ëü¾Í»á±£Ö¤¸ÃÇø¶ÎDNAÃâÊÜÏû»¯»ò½µ½â×÷Óá£ÔÚµçÓ¾Äý½ºµÄ·ÅÉä×ÔÏÔӰͼƬÉÏ£¬ÏàÓ¦ÓÚµ°°×ÖʽáºÏµÄ²¿Î»²»²úÉú·ÅÉäÐÔ±ê¼ÇµÄÌõ´ø¡£ Vq#_/23=$y  
c£® ¼×»ù»¯¸ÉÈÅÊÔÑé(Methylation interference assay) Gh9dv|m=[;  
ÓÃDMS´¦Àí°ÐDNA£¬Ê¹Æ½¾ùÿÌõÁ´ÉÏÖ»ÓÐÒ»¸öG±»¼×»ù»¯¡£½«¾Ö²¿¼×»ù»¯µÄDNAÓ뺬DNA½áºÏµ°°×µÄϸ°ûÌáÈ¡Îï¹²ÎÂÓýºó½øÐÐÄý½ºÖÍ»ºÊÔÑé¡£·ÖÀë¸÷ÖÖDNAÌõ´ø£¬²¢ÓÃÁùÇâßÁà¤Çиî¼×»ù»¯µÄ²Ð»ù¡£Èç¹ûÒòij¸öG²Ð»ùµÄ¼×»ù»¯×÷Óöø×èÖ¹Á˵°°×ÖÊÓëDNAµÄ½áºÏ£¬ÄÇô£¬ÁùÇâßÁशÔÕâ¸ö¼×»ù»¯G²Ð»ùµÄÇиî×÷Ó㬾ÍÖ»ÄÜÔÚûÓе°°×ÖʽáºÏµÄDNAÖй۲쵽¡£ .;~K*GC  
d£® ÌåÄÚ×ã¼£ÊÔÑé Q mn'G4#@E  
ÓÃÊÊÁ¿DMS´¦ÀíÍêÕûµÄÓÎÀëϸ°û£¬Ê¹È¾É«ÖÊÖеÄG²Ð»ù¼×»ù»¯£¬ÌáÈ¡DNA²¢¼ÓÈëÁùÇâßÁà¤ÇиîDNAÁ´¡£Óë¶ÔÕÕµÄÂã¶DNA¾­¼×»ù»¯´¦ÀíºóÐγɵÄÌݶÈÏà¶ÔÕÕ£¬¾ÍÄÜ·¢ÏÖDNAÁ´Éϵĵ°°×ÖʽáºÏÇø¡£ eFCXjM  
q9"~sCH  
Èý¡¢·Ö×Ó<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡¼¼Êõ "n=Ih_J  
1¡¢¸ßÖÊÁ¿mRNAµÄÖÆ±¸ tc<t%]c  
Ó¦ÓÃPromega PolyAT tract mRNA Isolation System·ÖÀëPoly(A)RNA¡£½«Biotinylated Oligo(dT)ÒýÎïÓëϸ°û×ÜRNA¹²ÎÂÓý£¬¼ÓÈëÓë΢´ÅÇòÏàÁ¬µÄStreptavidin£¬Óôų¡Îü¸½ÓëPMPÏàÁ¬µÄSA-Biotinylated Oligo(dT)-mRNA¡£ ._z[T@!9  
2£® ·´×ªÂ¼³ÉcDNA ihdtq  
¿ÉͬʱÔÚ·´×ªÂ¼ÏµÍ³ÖмÓÈëOligo£¨dT£©12-18-mer¼°Ëæ»úÒýÎïR6£¬ÒÔ±£Ö¤µÃµ½È«³¤cDNA£» A?8 29<  
ӦѡÓûîÐԽϸߵķ´×ªÂ¼Ã¸£¨Reverse transcriptase£©£» \M`fkR,,'  
ӦѡÓü׻ù»¯dCTP£» OT5'cl  
Ó¦±£Ö¤Ëù»ñµÃË«Á´cDNAµÄ·½ÏòÐÔ¡£ }ZWeb#\  
Super Script Choice cDNAºÏ³ÉϵͳÖÐËùÓõÄpoly£¨dT£©ÒýÎï >h m<$3  
ÒòΪ¾ø´ó¶àÊý´ó³¦¸Ë¾úϸ°û¶¼»áÇгý´øÓÐ5¡¯-methyl CµÄÍâÔ´DNA£¬ËùÒÔ£¬Ó¦Ñ¡ÓÃmcrA- mcrB-¾úÖê¡£ i@ avm7  
3£®·Ö×Ó<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡µÄÖ÷Òª·½·¨ lC i_G3C  
£¨1£©¹¹½¨cDNA¡¢ºËDNAÎĿ⣬ӦÓÃÏÖÓкËËá̽Õë·ÖÀëеÄÄ¿µÄ»ùÒò£» ~ Qt$)  
£¨2£©²îʽÔÓ½»(differential screen)ºÍ¿Û³ýÔÓ½»(subtractive hybridization)¼¼Êõ£» ,FPgbs  
£¨3£©DD-RT-PCR·¨¼°²î±ðÏÔʾ¼¼Êõ£» +<ey Iw  
£¨4£©²î±ð·ÖÎö·¨ (RDA·¨£¬¼´Representational difference analysis£©£» ,uP1U@Cas  
£¨5£©½Íĸ˫ÔÓ½»ÌåϵTwo-hybrid system£» /vB%gqJvX  
£¨6£©Í¼Î»<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡·¨£¨map-based cloning£©ÓëȾɫÌå²½ÒÆ £*****enomic DNA Walking£©¡£ Pne[>}_l/  
ϰ¹ßÉÏ£¬ÈËÃÇÓÃ<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡±íʾÓÉͬһÎïÖÖ¾ßÓÐÏàͬ»ùÒòÐ͵ÄÁ½¸ö»ò¶à¸ö¸öÌå×é³ÉµÄȺÌå¡£ËùÒÔ£¬´ÓͬһÊܾ«ÂÑ·ÖÁѶøÀ´µÄµ¥ÂÑË«Éú×Ó£¨monozygotic twins£©±ãÊôÓÚͬһ<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡¡£Ï¸°ûѧÉÏ£¬<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡ÊÇÖ¸ÓÉͬһ¸ö×æÏ¸°û£¨progenitor cell£©·ÖÁѶøÀ´µÄ¾ßÓÐͬһÒÅ´«±³¾°µÄ×Óϸ°ûȺÌå¡£·Ö×ÓÉúÎïѧÉÏ£¬°Ñ½«ÍâÔ´DNA²åÈë¾ßÓÐ×ÔÖ÷¸´ÖÆÄÜÁ¦µÄÔØÌåDNAÖУ¬Ê¹Ö®µÃÒÔ×ÔÖ÷¸´ÖƺÍÓÀ¾Ã±£´æµÄ¹ý³Ì½Ð×ö·Ö×Ó<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡¡£ w`Dzk. 2  
ÎÄ¿âɸѡÓë»ùÒò·á¶ÈÓйء£¸ß·á¶È»ùÒò£¬Èç²ÏË¿Ðĵ°°×£¬ÂÑÇåµ°°×µÈÔÚÄ³Ð©ÌØ¶¨×éÖ¯ÖпÉռϸ°û×ÜmRNAÁ¿µÄ50-90%£¬·Ç³£ÈÝÒ×±»·ÖÀë¡£µÍ·á¶È»ùÒò£¬Ò»°ãÔÚϸ°ûÖÐÖ»ÓÐ10-20¸ö¿½±´£¬²¸È鶯Îïϸ°ûÖпɺ¬10,000µ½40,000ÖÖ²»Í¬µÄmRNA£¬Èç¹ûÒª´ïµ½99%µÄÆÚÍûÖµ£¬´óÔ¼ÐèҪɸѡ150,000-170,000¸ö<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡×Ó¡£Ò»°ãÇé¿öÏ£¬Ã¿Î¢¿ËcDNA¿É²úÉú10Íò-60Íò¸ö<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡×Ó¡£  iV71t17  
A.²îʽÔÓ½»»ò¿Û³ýÔÓ½»<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡¼¼Êõ 7c6-S@L  
B.cRNA²îʽÏÔʾ·¨ JqH2c=}-  
³ýÁ˼«ÉÙÊýÌØÀý(Èç×éµ°°×»ùÒò)Ö®Í⣬¼¸ºõËùÓеÄÕæºË»ùÒòmRNA·Ö×ÓµÄ3¡¯-Ä©¶Ë£¬¶¼´øÓÐÒ»¶Î¶à¾ÛµÄÏÙÜÕËá½á¹¹£¬¼´Í¨³£Ëù˵µÄpoly(A)β°Í¡£ ?^&!/,  
P.LiangµÈÈËÉè¼ÆºÏ³ÉÁËÈ«²¿12ÖÖ²»Í¬µÄÒýÎÓÃÒÔ·´×ªÂ¼mRNA£¬ºÏ³ÉµÚÒ»Á´cDNA¡£ÕâÖÖÒýÎïͨ³£½Ð×÷3¡¯-¶Ë궨ÍÑÑõºËÜÕËáÒýÎ²¢ÓÃ5¡¯-T11MN»ò5¡¯-T12MNͨʽ±íʾ¡£ÆäÖÐMΪ³ýÁËTÒÔÍâµÄÈκÎÒ»ÖÖºËÜÕËᣨ¼´A¡¢G»òC£©£¬¶øNÔòΪÈκÎÒ»ÖÖºËÜÕËᣨ¼´A¡¢G¡¢C»òT£©£¬¹ÊMN¹²ÓÐ12ÖÖ²»Í¬µÄÅÅÁÐ×éºÏ·½Ê½¡£ R#bg{|  
DDRT-PCRµÄÖ÷Òª²½Ö裺 GKPqBi[rO  
¢ñ.´Ó²»Í¬·¢Óý½×¶Î»ò²»Í¬»ùÒòÐ͵Äϸ°ûȺÌåÖзÖÀëmRNA£¬²¢ÒÔ3¡¯Ãª¶¨ÒýÎï×÷Ϊ·´×ªÂ¼µÄÒýÎºÏ³ÉµÚÒ»¼ücDNA£» y\ @;s?QL  
¢ò.ÓÃ5¡¯Ëæ»úÒýÎïºÍij¸ö3¡¯¶Ë궨ÒýÎï¶ÔÀ©ÔöµÚÒ»Á´(²ôÈë32p-dNTP)£» zT~ GBC-IX  
¢ó.ÓÃDNA±äÐÔ²âÐò½º·ÖÀëÀ©Ôö²úÎX¹âÆ¬ÆØ¹âºó¼ì²â²î±ðÌõ´ø£» n@g[VR2t  
¢ô.»ØÊÕÌØÒìÐÔ²î±ðÌõ´ø£» cVn7jxf  
¢õ.ÓÃͬһÒýÎï¶ÔÀ©ÔöÒÑ»ØÊÕµÄDNAÌõ´ø£» L i=l/  
¢ö.ÓÃNorthern£¬Southern¼°²âÐò·¨·ÖÎöËùµÃµÄÌõ´ø£» &H5 6mL{  
¢÷.ÒÔ¸ÃDNAƬ¶Î×ö̽Õ룬ɸѡȫ³¤cDNA»òºË»ùÒò¡£ &TWO/F+Y  
C.cDNA²îʽ·ÖÎö·¨(Representational ditterence analysis) uD:O[H-x  
RDA·¨³ä·Ö·¢»ÓÁËPCRÒÔÖ¸ÊýÐÎʽÀ©ÔöË«Á´DNAÄ£°åµÄÌØÐÔ£¬Í¨¹ý½µµÍcDNAȺÌ帴ÔÓÐԺ͸ü»»cDNAÁ½¶Ë½ÓÍ·µÈ·½·¨£¬ÌØÒìÀ©ÔöÁËÄ¿µÄ»ùÒòƬ¶Î¡£ÒòΪÊÔÑé¶ÔÏó£¨Tester£©ºÍ¹©ÊÔ̽Õ루Driver£©ÔÚ½ÓÊܲîʽ·ÖÎöǰ¾ù¾­Ò»¸ö4¼î»ùÇиîø´¦Àí£¬ÐÎ³ÉÆ½¾ù³¤¶È256bpµÄ´ú±íȺ£¨representation£©±£Ö¤¾ø´ó²¿·ÖÒÅ´«ÐÅÏ¢Äܱ»À©Ôö¡£Ã¿´ÎT¼õD·´Ó¦ºó½öÉèÖÃ72¡æ¸´ÐÔÓëÑÓÉ죬94¡æ¸´ÐÔÕâÁ½¸ö²ÎÊý¹²20¸öPCRÑ­»·£¬PCR²úÎïµÄÌØÒìÐÔºÍËùµÃ̽ÕëµÄ´¿¶È·Ç³£¸ß¡£ { Rw~G&vQ  
D.½Íĸ˫ÔÓ½»Ìåϵ o(~JZi k  
Two-hybrid systemÒ²½Ðinteraction trap£¨Ï໥×÷ÓÃÏݾ®£©£¬ÊÇ90Äê´ú³õ·¢Õ¹ÆðÀ´µÄ·ÖÀë»ùÒòµÄз½·¨£¬¿ÉÓÃÓÚ·ÖÀëÄÜÓëÒÑÖª°Ðµ°°×ÖÊ£¨target protein£©Ï໥×÷ÓõĻùÒò¡£ 9i|6  
»ù±¾Ô­Àí£º a9jY^E'|n  
ÕæºËÉúÎïµÄת¼Òò×Ó´ó¶àÊÇÓÉÁ½¸ö½á¹¹ÉÏ·Ö¿ª¡¢¹¦ÄÜÉ϶ÀÁ¢µÄ½á¹¹Óò×é³ÉµÄ¡£ÈçGAL4µÄN¶Ë1-147aaÊÇDNA½áºÏÓò£¨BD£©£¬ÆäC¶Ë768-881aaÊÇת¼¼¤»îÓò£¨AD£©¡£Ò»°ãÇé¿öÏ£¬ADÄÜÓëGAL4ЧӦ»ùÒòÆô¶¯×ÓÉÏÓεÄÌØ¶¨DNAÇø¶Î£¨UAS£©Ïà½áºÏ£¬¶ø´Ëʱ£¬ADÔòÍÆ¶¯ÁËת¼Æðʼ¡£ Z@C D1+G  
ÈôÓûùÒò¹¤³ÌµÄ·½·¨£¬½«GAL4 ADºÍBD·Ö±ð<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡µ½²»Í¬µÄÔØÌåÉÏ£¬µ¼Èëͬһϸ°ûÖêÖбí´ï£¬Ð§Ó¦»ùÒòÎÞ·¨±»¼¤»î,µ«¿É°ÑÀ´×Ô²»Í¬×ªÂ¼Òò×ÓµÄAD»òBDÇøÓòÁ¬³ÉÒ»¸ö¹¦ÄÜ»ùÒò¡£ sQih yq6U;  
Ö÷ҪʵÑé¹ý³Ì£º xI:;%5{LN  
a. Ñ¡ÔñȱʧGAL4±àÂë»ùÒòµÄ½Íĸ¼ÄÖ÷¾úÖê-SFY526»òHF7c£» @1Zf&'/6  
b. ¹¹½¨´øÓÐGAL1 UAS-Æô¶¯×Ó-lac Z£¨His3£©µÄת»¯ÔØÌå; J;_JH lK  
c. °ÑÒÑÖªµÄ°Ðµ°°×ÖʱàÂë»ùÒò<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡µ½pGBT9µÄ¶à<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡λµãÉÏ£¬°ÑËùÓÐcDNA¶¼<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡µ½pGAD424ÔØÌåÉÏ£¬¹¹³ÉcDNA±í´ïÎĿ⡣ 6lWO8j^BN  
d. ´Ó´ó³¦¸Ë¾úÖзֱðÌáÈ¡ÕâÁ½ÖÖÖØ×éÖÊÁ£DNA£¬¹²×ª»¯¸ÐÊÜ̬Äð¾Æ½Íĸ¾úÖê¡£ ax>c&%vo  
e. ½«¹²×ª»¯µÄ½Íĸ¾úÖêÍ¿²¼ÓÚȱÉÙLeu£¬TrpºÍHisµÄÅàÑø»ùÉÏ£¬É¸Ñ¡±í´ïÏ໥×÷ÓõÄÔÓÖÖµ°°×µÄÑôÐÔ¾úÂä¡£ (c[h,>`@:  
E.»ùÒòµÄͼλ<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡·¨ {&h&:  
Map-based cloningÊÇ·ÖÀëδ֪ÐÔ×´Ä¿µÄ»ùÒòµÄÒ»Öֺ÷½·¨¡£´ÓÀíÂÛÉÏ˵£¬ËùÓоßÓÐijÖÖ±íÏÖÐ͵ĻùÒò¶¼¿ÉÒÔͨ¹ý¸Ã·½·¨<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡µÃµ½¡£Ê×ÏÈ£¬½«Ä¿µÄ»ùÒò¶¨Î»µ½Ä³¸öȾɫÌåµÄÌØ¶¨Î»µã£¬²¢ÔÚÆäÁ½²àÈ·¶¨½ôÃÜÁ¬ËøµÄRFLP»òRAPD·Ö×Ó±ê¼Ç¡£¶þ¡¢ÀûÓÃÓëÄ¿µÄ»ùÒò×î½ôÃÜÁ¬ËøµÄÒ»¶Ô·Ö×Ó±ê¼Ç×÷̽Õ룬ͨ¹ýȾɫÌå²½ÒÆ¼¼Êõ½«Î»ÓÚÕâÁ½¸ö±ê¼ÇÖ®¼äµÄ»ùÒòƬ¶Î<A&NBSP;CLASS=¡¯CHANNEL_KEYLINK¡¯&NBSP;HREF=¡¯HTTP: www.bbioo.com Article Search.asp?Field="Title&ClassID=&keyword=%BF%CB%C2%A1&Submit=+%CB%D1%CB%F7+¡¯">¿Ë¡²¢·ÖÀë³öÀ´¡£Èý¡¢¸ù¾Ý»ùÒò¹¦ÄÜ»¥×÷Ô­Àí¼ø¶¨Ä¿µÄ»ùÒò¡£ / V {w<  
ͨ¹ý¶ÔÐí¶à²»Í¬µÄÉú̬Ðͼ°´óÁ¿ÏÞÖÆÐÔÄÚÇÐøºÍÔÓ½»Ì½ÕëµÄ·ÖÎö£¬ÕÒ³öÓëÄ¿µÄ»ùÒò¾àÀë×î½üµÄRFLP±ê¼Ç¡£ÔÚRFLP×÷ͼÖУ¬Á¬Ëø¾àÀëÊǸù¾ÝÖØ×éÂÊÀ´¼ÆËãµÄ£¬1cm£¨ÀåÃ×£©Ï൱ÓÚ1%µÄÖØ×éÂÊ¡£ÈËÀà»ùÒò×éÖУ¬1cm¡Ö1000kb;ÄâÄϽæ²ËÖУ¬1cm¡Ö290kb;СÂóÖУ¬ 1cm¡Ö3500kb¡£ ?4lAL  
ZA9']u%EJ  
ËÄ¡¢ DNAµÄMicroarray o$-8V:)6d  
Ö»ÒªÊÂÏȳýÈ¥¸ß¶È¼°ÖеÈÖØ¸´ÐòÁУ¬ÈκÎDNA¶¼¿ÉÒÔ±»ÓÃÓÚMicroarray¡£×î¼òµ¥µÄÀý×ÓÊÇÓûúеÊְѼ«Î¢Á¿£¨nanoliters£©µÄDNAµãµ½²£Æ¬»òÆäËüÔØÌåÉÏ£¬ÕÕÉäUV lightʹ֮ÓÀ¾Ã¹Ì¶¨£¬Óò»Í¬Ï¸°ûÖÜÆÚ·¢Óý½×¶ÎµÄcDNA×÷̽ÕëϵͳÐÔµØÑо¿Ï¸°ûÖÐÈÎÒâʱÆÚÌØÒì±í´ïµÄ»ùÒò£»Èô°ÑijһÉúÎïÌåÄÚÈ«²¿È«²¿ÒÑÖª»ùÒò·Ö±ðµãµ½DNA΢ÁÐÕó»òÕß»ùÒòоƬÉÏ£¬ÔÙÓò»Í¬·¢Óý½×¶ÎµÄcDNAÓëÖ®ÔÓ½»£¬¾ÍÄÜÁ˽âijЩ»ùÒò¶ÔÌØ¶¨Éú³¤·¢Óý½×¶ÎµÄÖØÒªÐÔ£»»ùÒòоƬ»¹¿ÉÓÃÓÚ½øÐлùÒòÕï¶Ï£¬¿É½¨Á¢Õý³£ÈËÌØ¶¨×éÖ¯¡¢Æ÷¹ÙµÄ»ùÒòоƬ£¬¸ø³ö±ê×¼ÔÓ½»ÐźÅͼ¡£ÓÿÉÒɲ¡È˵ÄcDNA×ö̽ÕëÓëÖ®ÔÓ½»£¬¼ì²éÄÄЩ»ùÒòµÄ±í´ïÊÜÒÖÖÆ»ò¼¤»î¡£ T:!sfhrZ~<  
40 c#zCE  
Y\%}VD2k  
"BVz5?  
@`_j't,  
Bw#ubQJ8}  
--------------------------------------------------------------------------------------------- SY$%!! @R  
f<}!A$wd  
|@@mq!>-  
µÚÁù½² Ô­ºË»ùÒò±í´ïµ÷¿Ø T *{zL  
Ô­ºËÉúÎïºÍµ¥Ï¸°ûÕæºËÉúÎïÖ±½Ó±©Â¶ÔÚ±ä»ÃβâµÄ»·¾³ÖУ¬Ê³Î﹩ӦºÁÎÞ±£ÕÏ£¬Ö»ÓÐÄܸù¾Ý»·¾³Ìõ¼þµÄ¸Ä±äºÏ³É¸÷ÖÖ²»Í¬µÄµ°°×ÖÊ£¬Ê¹´úл¹ý³ÌÊÊÓ¦»·¾³µÄ±ä»¯£¬²ÅÄÜά³Ö×ÔÉíµÄÉú´æºÍ·±ÑÜ¡£×ÔȻѡÔñÇãÏòÓÚ±£Áô¸ßЧÂʵÄÉúÃü¹ý³Ì¡£ÔÚÒ»¸öÿ30minÔöÖ³Ò»±¶µÄ109ϸ¾úȺÌåÖУ¬ÈôÓÐÒ»¸öϸ¾ú±ä³ÉÁË29.5minÔöÖ³Ò»±¶£¬´óÔ¼¾­¹ý80ÌìµÄÁ¬ÐøÉú³¤ºó£¬Õâ¸öȺÌåÖеÄ99.9%¶¼½«¾ßÓÐ29.5minÔöÖ³Ò»±¶µÄÉú³¤ËÙ¶È¡£ c\] L  
4KM$QHS5{  
Ò»¸ö´ó³¦¸Ë¾úϸ°ûÖÐÔ¼ÓÐ2500-3000¸ö»ùÒò¡£¹À¼ÆÕý³£Çé¿öÏ£¬¿É´øÓÐ107¸öµ°°×ÖÊ£¬Æ½¾ùÿ¸ö»ùÒò²úÉú3000¶à¸öµ°°×ÖÊ·Ö×Ó¡£µ«´ó³¦¸Ë¾úÖÐÒ»°ã´øÓÐ15,000-30,000¸öºËÌÇÌ壬ÓÐ50ÓàÖÖºËÌÇÌå½áºÏµ°°×£¬ÊýÁ¿Ò²ºÜ¾ªÈË¡£´ËÍ⣬¸ºÔðÌǽͽâϵͳµÄµ°°×ÖÊÊýÁ¿Ò²ºÜ´ó¡£¶øÏó°ëÈéÌÇÜÕøµÈÓÕµ¼Ã¸£¬Æäº¬Á¿¿ÉÉÙÖÁÿϸ°û½ö1-5¸ö·Ö×Ó¡£ ^6 LFho4  
,m"zt u-  
Ò»¸öÌåϵÔÚÐèҪʱ±»´ò¿ª£¬²»ÐèҪʱ±»¹Ø±Õ¡£ÕâÖÖ"¿ª-¹Ø"£¨on-off£©»îÐÔÊÇͨ¹ýµ÷½Úת¼À´½¨Á¢µÄ£¬Ò²¾ÍÊÇ˵mRNAµÄºÏ³ÉÊÇ¿ÉÒÔ±»µ÷½ÚµÄ¡£µ±ÎÒÃÇ˵һ¸öϵͳ´¦ÓÚ"off"״̬ʱ£¬Ò²Óб¾µ×ˮƽµÄ»ùÒò±í´ï£¬³£³£ÊÇÿÊÀ´úÿ¸öϸ°ûÖ»ºÏ³É1»ò2¸ömRNA·Ö×Ó¡£Ëùν"¹Ø"ʵ¼ÊµÄÒâ˼ÊÇ»ùÒò±í´ïÁ¿ÌرðµÍ£¬ºÜÄÑÉõÖÁÎÞ·¨¼ì²â¡£ n47=eKd70  
U.)G #B  
¿ÆÑ§¼Ò°ÑÕâ¸ö´ÓDNAµ½µ°°×ÖʵĹý³Ì³ÆÎª»ùÒò±í´ï(gene expression)£¬¶ÔÕâ¸ö¹ý³ÌµÄµ÷½Ú¾Í³ÆÎª»ùÒò±í´ïµ÷¿Ø(gene regulation»ògene control)¡£ÒªÁ˽⶯¡¢Ö²ÎïÉú³¤·¢ÓýµÄ¹æÂÉ¡¢ÐÎ̬½á¹¹ÌØÕ÷ºÍÉúÎïѧ¹¦ÄÜ£¬¾Í±ØÐëŪÇå³þ»ùÒò±í´ïµ÷¿ØµÄʱ¼äºÍ¿Õ¼ä¸ÅÄî£¬ÕÆÎÕÁË»ùÒò±í´ïµ÷¿ØµÄÃØÃÜ£¬ÎÒÃÇÊÖÖоÍÓÐÁËÒ»°Ñ½ÒʾÉúÎïѧ°ÂÃîµÄ½ðÔ¿³×¡£ j0%0yb{-^  
V%0.%/<#5  
»ùÒò±í´ïµ÷¿ØÖ÷Òª±íÏÖÔÚÒÔϼ¸¸ö·½Ã棺 0%qUTGj  
¢Ù ת¼ˮƽÉϵĵ÷¿Ø(transcriptional regulation)£» wr$}AX  
¢Ú mRNA¼Ó¹¤³ÉÊìˮƽÉϵĵ÷¿Ø(differen, tial processing of RNA transcript)£» `;_tt_  
¢Û ·­ÒëˮƽÉϵĵ÷¿Ø(differential translation of mRNA). lQsQRp  
BH-[q9pf  
Ô­ºËÉúÎïÖУ¬ÓªÑø×´¿ö(nutritionalstatus)ºÍ»·¾³ÒòËØ(environmental factor)¶Ô»ùÒò±í´ïÆðמÙ×ãÇáÖØµÄÓ°Ïì¡£ÔÚÕæºËÉúÎïÓÈÆäÊǸߵÈÕæºËÉúÎïÖУ¬¼¤ËØË®Æ½(hormone level)ºÍ·¢Óý½×¶Î(developmental stage)ÊÇ»ùÒò±í´ïµ÷¿ØµÄ×îÖ÷ÒªÊֶΣ¬ÓªÑøºÍ»·¾³ÒòËØµÄÓ°ÏìÁ¦´óΪϽµ¡£ rq1kj 8%2  
{\aSEE /'  
Ò»¡¢ ÈéÌDzÙ×Ý×ӵĵ÷¿ØÄ£Ê½ O|>1~^w  
´ó³¦¸Ë¾úÈéÌDzÙ×Ý×Ó(lactose operon)°üÀ¨3¸ö½á¹¹»ùÒò£ºZ¡¢YºÍA£¬ÒÔ¼°Æô¶¯×Ó¡¢¿ØÖÆ×ÓºÍ×è¶ô×ӵȡ£×ªÂ¼Ê±£¬RNA¾ÛºÏøÊ×ÏÈÓëÆô¶¯Çø(promoter,P)½áºÏ£¬Í¨¹ý²Ù×ÝÇø(operator,O)ÏòÓÒת¼¡£×ªÂ¼´ÓOÇøµÄÖм俪ʼ£¬°´Z¡úY¡úA·½Ïò½øÐУ¬Ã¿´Îת¼³öÀ´µÄÒ»ÌõmRNAÉ϶¼´øÓÐÕâ3¸ö»ùÒò¡£×ªÂ¼µÄµ÷¿ØÊÇÆô¶¯ÇøºÍ²Ù×ÝÇø½øÐеġ£ zkp Apj].  
~^^ey17   
Z±àÂë¦Â-°ëÈéÌÇÜÕø£»Y±àÂë¦Â-°ëÈéÌÇÜÕ͸¹ýø£»A±àÂë¦Â-°ëÈéÌÇÜÕÒÒõ£»ù×ªÒÆÃ¸¡£¦Â-°ëÈéÌÇÜÕøÊÇÒ»ÖÖ¦Â-°ëÈéÌÇÜÕ¼üµÄרһÐÔø£¬³ýÄܽ«ÈéÌÇË®½â³ÉÆÏÌÑÌǺͰëÈéÌÇÍ⣬»¹ÄÜË®½âÆäËû¦Â-°ëÈéÌÇÜÕ£¨Èç±½»ù°ëÈéÌÇÜÕ£©¡£¦Â-°ëÈéÌÇÜÕ͸¹ýøµÄ×÷ÓÃÊÇʹÍâ½çµÄ¦Â-°ëÈéÌÇÜÕ£¨ÈçÈéÌÇ£©ÄÜ͸¹ý´ó³¦¸Ë¾úϸ°û±ÚºÍÔ­ÉúÖÊĤ½øÈëϸ°ûÄÚ¡£¦Â-°ëÈéÌÇÜÕÒÒõ£»ù×ªÒÆÃ¸µÄ×÷ÓÃÊǰÑÒÒõ£¸¨Ã¸AÉϵÄÒÒõ£»ùתµ½¦Â-°ëÈéÌÇÜÕÉÏ£¬ÐγÉÒÒõ£°ëÈéÌÇ¡£ }R1`ThTM  
j&/.[?K  
1£® øµÄÓÕµ¼-lacÌåϵÊܵ÷¿ØµÄÖ¤¾Ý O&,O:b:@  
ÔÚ²»º¬ÈéÌǼ°¦Â-°ëÈéÌÇÜÕµÄÅàÑø»ùÖУ¬lac+»ùÒòÐÍÿ¸ö´ó³¦¸Ë¹¦Ï¸°ûÄÚ´óÔ¼Ö»ÓÐ1-2¸öø·Ö×Ó¡£Èç¹ûÔÚÅàÑø»ùÖмÓÈëÈéÌÇ£¬Ã¸µÄŨ¶ÈºÜ¿ì´ïµ½Ï¸°û×ܵ°°×Á¿µÄ6%»ò7%£¬Ã¿¸öϸ°ûÖпÉÓг¬¹ý105¸öø·Ö×Ó¡£ BJ9sR.yX62  
;-?ZI$  
¿ÆÑ§¼Ò°Ñ´ó³¦¸Ë¾úϸ°û·ÅÔÚ¼ÓÓзÅÉäÐÔ35S±ê¼ÇµÄ°±»ùËᵫûÓÐÈκΰëÈéÌÇÓÕµ¼ÎïµÄÅàÑø»ùÖз±Ö³¼¸´ú£¬È»ºóÔÙ½«ÕâЩ´øÓзÅÉä»îÐÔµÄϸ¾ú×ªÒÆµ½²»º¬35S¡¢ÎÞ·ÅÉäÐÔµÄÅàÑø»ùÖУ¬Ëæ×ÅÅàÑø»ùÖÐÓÕµ¼ÎïµÄ¼ÓÈ룬¦Â-°ëÈéÌÇÜÕø±ã¿ªÊ¼ºÏ³É¡£·ÖÀë¦Â-°ëÈéÌÇÜÕø£¬·¢ÏÖÕâÖÖøÎÞ35S±ê¼Ç¡£ËµÃ÷øµÄºÏ³É²»ÊÇÓÉǰÌåת»¯¶øÀ´µÄ£¬¶øÊǼÓÈëÓÕµ¼Îïºóкϳɵġ£ +?iM$}8!U  
i$ L]X[  
ÒѾ­·ÖÀëÔÚÓÐÓÕµ¼Îï»òûÓÐÓÕµ¼ÎïµÄÇé¿ö϶¼ÄܲúÉúlacmRNAµÄÍ»±äÌ壬ÕâÖÖʧȥµ÷½ÚÄÜÁ¦µÄÍ»±äÌå³ÆÎªÓÀ¾ÃÐÍÍ»±äÌ壬Ϊ·ÖÁ½ÀࣺIÐͺÍOÐÍ¡£  y"\,%.  
4VNb`!e  
IÐÍ£ºÒ°ÉúÐÍΪI+£¬Í»±äÐÍΪI- vS YKe  
OÐÍ£ºÒ°ÉúÐÍΪO+£¬Í»±äÐÍΪOc¡£ e(#IewKp  
h_~|O [5|)  
I+¡úI-»òO+¡úOcºó£¬Z¡¢Y¡¢A½á¹¹»ùÒò¾ù±íÏÖΪÓÀ¾Ã±í´ï£¬ËùÒÔI»ùÒò±»³ÆÎªµ÷½Ú»ùÒò(regulatory gene)¡£Ñо¿·¢ÏÖ£¬I»ùÒòÊÇÒ»¸ö²úÉú×è¶ôÎïµÄµ÷½Ú»ùÒò£¬Æä²úÎïʹÌåϵ¹Ø±Õ¡£I-Í»±äÌåÓÉÓÚ²»ÄܲúÉú×è¶ôÎʹϸ°û³ÉΪlacÓÀ¾Ã±í´ïÐÍ¡£I-/I+¾Ö²¿¶þ±¶ÌåÓÉÓÚ´øÓÐÒ»¸öÕý³£×è¶ôÎʹϸ°ûÖеÄlacÈÔÈ»±»ÒÖÖÆ¡£ z"K( bw6  
~B!O~nvdQ  
ÒÅ´«Ñ§Í¼Æ×·ÖÎöÖ¸³ö£¬OcÍ»±äλÓÚIÓëZÖ®¼ä£¬ËùÒÔ£¬lacÌåϵµÄ4¸ö»ùÒòµÄÐòÁÐΪIOZY¡£Í¨¹ýÕâЩ¹Û²ì£¬JacobºÍMonodÍÆ¶ÏOcÍ»±ä´ú±íDNAÁ´ÉϵÄÒ»¸öλµã»òÒ»¸ö·Ç±àÂëÇøÓò£¬¶ø²»ÊÇÒ»¸ö»ùÒò£¬ÒòΪ¿É±àÂëµÄ»ùÒò¾ßÓл¥²¹ÐÔ£¬¶øOcûÓÐÕâÒ»ÌØÐÔ¡£O¾ö¶¨ÏàÁÚZ»ùÒòµÄ²úÎïÊÇÓÕµ¼Ðͺϳɻ¹ÊÇÓÀ¾ÃÐͺϳɣ¬OÇøÓò³ÆÎª²Ù×Ý»ùÒò¡£ kz0=GKic  
;:Z=%R$wJ  
2. ²Ù×Ý×ÓÄ£ÐÍ lmQ6X  
JacobºÍMonodÈÏΪÓÕµ¼Ã¸£¨ËûÃǵ±Ê±³ÆÎªÊÊӦø£©ÏÖÏóÊǸö»ùÒòµ÷¿ØÎÊÌ⣬¿ÉÒÔÓÃʵÑé·½·¨½øÐÐÑо¿£¬Òò´ËÑ¡ÎªÍ»ÆÆ¿Ú£¬ÖÕÓÚͨ¹ý´óÁ¿ÊµÑé, ¼°·ÖÎö£¬½¨Á¢Á˸òÙ×Ý×ӵĿØÖÆÄ£ÐÍ¡£ @vQa\|j  
_IL2-c8  
¢Ù Z¡¢Y¡¢A»ùÒòµÄ²úÎïÓÉͬһÌõ¶à˳·´×ÓµÄmRNA·Ö×ÓËù±àÂë¡£ `x} Dk<HF  
¢Ú Õâ¸ömRNA·Ö×ӵįô¶¯×Ó½ô½Ó×ÅOÇø£¬¶øÎ»ÓÚIÓëOÖ®¼äµÄÆô¶¯×ÓÇø£¨P£©£¬²»Äܵ¥¶ÀÆð¶¯ºÏ³É¦Â-°ëÈéÌÇÜÕøºÍ͸¹ýøµÄÉúÀí¹ý³Ì¡£ h/Hl?O8[  
¢Û ²Ù×Ý»ùÒòÊÇDNAÉϵÄһС¶ÎÐòÁУ¨½öΪ26bp£©£¬ÊÇ×è¶ôÎïµÄ½áºÏλµã¡£ S9p?*  
¢Üµ±×è¶ôÎïÓë²Ù×Ý»ùÒò½áºÏʱ£¬lacmRNAµÄת¼ÆðʼÊܵ½ÒÖÖÆ¡£ Vf 0fT?/K  
¢ÝÓÕµ¼Îïͨ¹ýÓë×è¶ôÎï½áºÏ£¬¸Ä±äËüµÄÈýά¹¹Ïó£¬Ê¹Ö®²»ÄÜÓë²Ù×Ý»ùÒò½áºÏ£¬´Ó¶ø¼¤·¢lacmRNAµÄºÏ³É¡£µ±ÓÐÓÕµ¼Îï´æÔÚʱ£¬²Ù×Ý»ùÒòÇøÃ»Óб»×è¶ôÎïÕ¼¾Ý£¬ËùÒÔÆô¶¯×ÓÄܹ»Ë³ÀûÆðʼmRNAµÄºÏ³É¡£ T|@#w%c''  
85D^@{  
3. Lac²Ù×Ý×ӵı¾µ×ˮƽ±í´ï =4zNo3IvL+  
ÒòΪÓÕµ¼ÎïÐèÒª´©¹ýϸ°ûĤ²ÅÄÜÓë×è¶ôÎï½áºÏ£¬¶øÔËתÓÕµ¼ÎïÐèҪ͸¹ýø¡£ÔÚ·ÇÓÕµ¼×´Ì¬ÏÂÓÐÉÙÁ¿£¨1-5¸ömRNA·Ö×Ó£©lac mRNAºÏ³É--±¾µ×ˮƽÓÀ¾ÃÐͺϳɡ£ t<sNc8x  
@Y UY9+D&  
4. ÆÏÌÑÌǶÔlac²Ù×Ý×ÓµÄÓ°Ïì--´úлÎï×è¶ôЧӦ YOV :  
Ñо¿±íÃ÷£¬ÆÏÌÑÌǶÔlac²Ù×Ý×Ó±í´ïµÄÒÖÖÆ×÷ÓÃÊǼä½ÓµÄ£¬ÒòΪ´æÔÚÒ»Öִ󳦸˾úÍ»±äÖ꣬ËüÕý³£µÄÌǽͽâ¹ý³ÌÊÜ×裬ÆÏÌÑÌÇ-6-Á×Ëá²»ÄÜת»¯ÎªÏÂÒ»²½´úлÖмäÎ¸Ã¾úÖêÄÜÔÚÓÐÆÏÌÑÌÇ´æÔÚµÄÇé¿öϱ»ÓÕµ¼ºÏ³Élac mRNA¡£ 2@ 9pr  
k&) K(  
5. cAMPÓë´úлÎD»îµ°°× dL_QX,X-]  
µ±ÆÏÌÑÌǺÍÈéÌÇͬʱ´æÔÚÓÚÅàÑø»ùÖÐʱ£¬lacÆô¶¯×Ó±í´ïÊÜ×裬ûÓЦÂ-°ëÈéÌÇÜÕø»îÐÔ£»µ±ÆÏÌÑÌÇÏûºÄÍêÒÔºó£¨Í¼ÖмýÍ·´¦£©£¬Ï¸°ûÄÚcAMPŨ¶ÈÔö¼Ó£¬¦Â-°ëÈéÌÇÜÕø»îÐÔ±»ÓÕµ¼£¬Ò»¶ÈÍ£Ö¹Éú³¤µÄϸ°ûÓÖ»Ö¸´·ÖÁÑ¡£Èç¹û½«Ï¸¾ú·ÅÔÚȱ·¦Ì¼Ô´µÄÅàÑø»ùÖУ¬Ï¸°ûÄÚcAMPŨ¶È¾ÍºÜ¸ß£»ÈôÔÚº¬ÆÏÌÑÌǵÄÅàÑø»ùÖÐÅàÑø£¬Ï¸¾úÖеÄcAMPŨ¶È¾Í»áºÜµÍ£»Èç¹û½«Ï¸¾úÖÃÓÚ¸ÊÓÍ»òÈéÌǵȲ»½øÐÐÌǽͽâµÄ̼ԴÅàÑø»ùÖУ¬Ï¸¾úÖÐcAMPµÄŨ¶ÈÒ²»áºÜ¸ß¡£ aDL)|>"Q  
~BZXt7DE  
Ñо¿Ö¤Êµ£¬ÆÏÌÑÌÇËùÒýÆðµÄ´úлÎïÒÖÖÆ(Catabolite repression)ÏÖÏóµÄʵÖÊÊǸôúлÎï½µµÍÁËϸ°ûÖÐcAMPµÄº¬Á¿.ÊÂʵÉÏ£¬cAMP-CAP¸´ºÏÎïÊÇlacÌåϵµÄpositive regulator£¬ËüÃDz»ÄÜ´úÌælacIºÍlacOµÄ¹¦ÄÜ(negative regulator)¡£ )N(9pnyZH  
lC#RNjDp/~  
cAMP-CAP²»µ«ÄÜÓëDNAÏà½áºÏ£¬Ôì³ÉË«ÂÝÐýÍäÇú£¬Ò×ÓÚÐγÉÈýԪת¼Æðʼ¸´ºÏÎËü»¹ÄÜÖ±½ÓÓ°ÏìRNA¾ÛºÏøµÄ»îÐÔ¡£Dominant negative£¨Trans-dominant£©lacI-d£¬Ö»ÒªÓÐÕâ¸ö"»·"µÄÑÇ»ù´æÔÚ£¬lacI+»ùÒò²úÎ×è¶ôÎÎÞ·¨ÓëOÇøÏà½áºÏlac operonµÃµ½±í´ï¡£ RF_[?O)Q  
o+<29o  
6. lac²Ù×Ý×ÓDNAµÄµ÷¿ØÇøÓò--P.O.Çø AnNP Ti  
lac P£¨Æô¶¯×ÓÇø£©´ÓI»ùÒò½áÊøµ½mRNAת¼ÆðʼλµãÖ¹£¬¹²³¤82bp£¨-82¡«+1£©OÇø¾ÍÊÇ×è¶ôÎï½áºÏÇø£¬Î»ÓÚPÇøºó°ë²¿·ÖºÍת¼ÆðÊ¼Çø£¨-7¡«+28£©£¬¸ÃÇøÐòÁÐÓжԳÆÐÔ£¬Æä¶Ô³ÆÖÐÐĵãÔÚ+11λ¡£PÇøµÄCAMP-CAP½áºÏÇø£¨-67¡«-52£©Ò²ÓжԳÆÐÔ£¬Æä¶Ô³ÆÎ»µãÔÚ-60¡«-59Ö®¼ä¡£ -bypuMQ-p  
E eCFII  
ÔÚÒ»¸öÍêÈ«±»ÓÕµ¼µÄϸ°ûÖУ¬¦Â-°ëÈéÌÇÜÕø¡¢Í¸¹ýø¼°ÒÒõ£»ù×ªÒÆÃ¸µÄ¿½±´Êý±ÈÀýΪ1:0.5:0.2£¬Õâ¸ö±ÈÀýÔÚÒ»¶¨³Ì¶ÈÉÏ·´Ó³ÁËÒÔ¦Â-°ëÈéÌÇÜÕ×÷ΪΨһ̼Դʱϸ°ûµÄÐèÒª¡£²»Í¬µÄøÔÚÊýÁ¿ÉϵIJîÒìÊÇÓÉÓÚÔÚ·­ÒëˮƽÉÏÊܵ½µ÷½ÚËùÖ¡£ ^7uX$  
+W 9]ED  
¢Ùlac mRNA¿ÉÄÜÓë·­Òë¹ý³ÌÖеĺËÌÇÌåÏàÍÑÀ룬´Ó¶øÖÕÖ¹µ°°×ÖÊÁ´µÄ·­Òë¡£ÕâÖÖÏÖÏó·¢ÉúµÄƵÂÊÈ¡¾öÓÚÿһ¸öºóÐøµÄAUGÃÜÂë×ÓÔÙ¶ÈÆðʼ·­ÒëµÄ¸ÅÂÊ¡£ 2H[ ; v+  
¢ÚÔÚlac mRNA·Ö×ÓÄÚ²¿£¬A»ùÒò±ÈZ»ùÒò? u4YM^* S.  
@,k7xm$u  
[p:3]
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
¼¶±ð: ³õ¼¶²©ÓÑ
ÏÔʾÓû§ÐÅÏ¢ 
ɳ·¢  ·¢±íÓÚ: 2009-09-08   
ºÃÌùÒ»¶¨Òª¶¥ÆðÀ´£¡
¼¶±ð: ³õ¼¶²©ÓÑ
ÏÔʾÓû§ÐÅÏ¢ 
°åµÊ  ·¢±íÓÚ: 2009-09-10   
¸Ðл£¡£¡£¡
¼¶±ð: Öм¶²©ÓÑ
ÏÔʾÓû§ÐÅÏ¢ 
µØ°å  ·¢±íÓÚ: 2009-09-10   
лл¥Ö÷£¬ÐÁ¿àÁË¡£ÎÒÖ§³ÖÄã¡£
¼¶±ð: Öм¶²©ÓÑ
ÏÔʾÓû§ÐÅÏ¢ 
µØÏÂÊÒ  ·¢±íÓÚ: 2009-09-10   
¹ýÀ´Ñ§Ï°Ò»Ï£¡ÐÁ¿àÁË¡¤¡¤¡¤
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
4+6=? ÕýÈ·´ð°¸:10
°´"Ctrl+Enter"Ö±½ÓÌá½»